The current financial score of Evolent Health Inc is 7.34. Its financial status is weak, and its operating efficiency is high. Its latest quarterly revenue reached 652.52M, representing a year-over-year increase of 46.86%, while its net profit experienced a year-over-year increase of 44.48%.
The current valuation score of Evolent Health Inc is 8.44. Its current P/E ratio is -0.79, which is -45.70% below the recent high of -0.43 and -22121.07% above the recent low of -175.04.
The current earnings forecast score of Evolent Health Inc is 7.87. The average price target is 6.46, with a high of 15.00 and a low of 3.00.
The current price momentum score of Evolent Health Inc is 5.75. Currently, the stock price is trading between the resistance level at 4.61 and the support level at 3.20, making it suitable for range-bound swing trading.
The current institutional shareholding score of Evolent Health Inc is 10.00. The latest institutional shareholding proportion is 109.51%, representing a quarter-over-quarter decrease of 19.86%.
The current risk assessment score of Evolent Health Inc is 3.75. The company's beta value is 0.84. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.